Listen

Description

With Dr. Abraham Morgentaler and Dr. Marianne Brandon

Listen to the podcast on all of your favorite platforms:
Apple: https://podcasts.apple.com/ec/podcast/the-sex-doctors/id1761813985?l=en-GB
Spotify: https://open.spotify.com/show/0apSFzquJXKoOGnmI6ndgT?si=e5a1e482c7ca46c7

Find us on:
Instagram: https://www.instagram.com/thesexdoctors?utm_source=ig_web_button_share_sheet&igsh=ZDNlZDc0MzIxNw==
Facebook: https://www.facebook.com/thesexdoctors
YouTube: https://www.youtube.com/@thesexdoctorspod
TikTok: https://www.tiktok.com/@thesexdoctor
LinkedIn (Dr. Abraham): https://www.linkedin.com/in/abraham-morgentaler-md-81628b6
LinkedIn (Dr. Marianne): https://www.linkedin.com/in/mariannebrandon-59224513
X (Dr. Abraham): https://x.com/DrMorgentaler
X (Dr. Marianne): https://x.com/drbrandon

In this episode, Dr. Brandon and Dr. Morgentaler talk about the safety of hormone replacement therapy after age 65, breaking down common misconceptions from the WHI study and explaining why many fears about starting hormones later in life may be overstated.

00:00 – Listener Question on Late HRT
A listener asks whether starting hormone replacement therapy more than 10 years after menopause is safe, sparking a discussion on hormones after age 65.

01:56 – WHI Study Misread and Risk Math
The doctors break down how the WHI study was widely misinterpreted and explain the actual breast cancer risk numbers behind the headlines.

15:43 – New Study After 65
A recently published study raises concerns about starting hormone therapy after age 65, prompting a closer look at its findings.

17:22 – Study Design Red Flags
Dr. Morgentaler highlights major flaws in the study's methodology and explains why he believes the results are not reliable.

23:36 – Peer Review Pitfalls
The conversation explores how questionable research can still make it through peer review and influence medical opinions.

28:17 – HRT After 65 Guidance
The doctors discuss why many women may still benefit from hormone therapy later in life and how treatment decisions should be individualized.

#hormonereplacementtherapy #womenshealth #menopauseresearch